4don MSN
ADT outlines $5.1B–$5.2B revenue target while expanding ADT+ and accelerating AI-driven cost savings
Discover ADT’s Q3 2025 earnings highlights: strong revenue growth, AI-driven efficiency, and confident outlook.
3don MSN
Pulse Biosciences targets Q1 completion of PRECISE-BTN study enrollment as clinical adoption grows
Get the latest on Pulse Biosciences’ Q3 2025 earnings: commercial growth, FDA progress, and clinical trial updates in soft tissue and cardiac therapies.
— The Trump administration has struck a deal to drop the cost of popular obesity drugs to $149 per month, at least in some cases, Ruth reports. Klomp spilled the beans during a fireside chat at Milken ...
BAER Bridger Aerospace Group Holdings, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback